Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 180.50
-2.00 (-1.10%)
Oct 8, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 48.68 billion as of October 9, 2026. It is the 8,042nd most valuable company in the world and the 243rd biggest in Taiwan. Its market cap has decreased by 33.42% in one year.
Market Cap
48.68B
Enterprise Value
100.80B
Revenue
28.49B
Global Rank
Country Rank
#243 Taiwan
PE Ratio
12.69
ChartMarket Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 48.68B, an increase of 429.84%. That is a compound annual growth rate of 14.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 48.68B | -34.59% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 53.72B |
| Center Laboratories | 24.52B |
| Handa Pharmaceuticals | 20.80B |
| TTY Biopharm Company | 19.82B |
| Synmosa Biopharma | 15.77B |
| YungShin Global Holding | 15.29B |
| ScinoPharm Taiwan | 14.87B |
| Grape King Bio | 12.52B |